GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Enorama Pharma ERMA.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.76

-4.75%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Enorama Pharma annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
RevenueSEK 2.7mSEK 15.8mSEK 1.4mSEK 6.8mSEK 11.0m
Operating income−SEK 62.8m−SEK 47.5m−SEK 43.7m−SEK 40.8m−SEK 26.9m
Net income−SEK 75.1m−SEK 43.8m−SEK 44.6m−SEK 41.8m−SEK 28.5m
Free cash flow−SEK 118.5m−SEK 35.7m−SEK 41.3m−SEK 33.0m−SEK 32.0m
Total assetsSEK 8.3mSEK 15.9mSEK 34.4mSEK 48.7mSEK 50.9m
Shareholders' equity−SEK 23.5mSEK 7.8mSEK 19.5mSEK 31.5mSEK 21.4m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.